CD44: a validated target for improved delivery of cancer therapeutics

MLA

Jim Klostergaard, et al. “CD44: A Validated Target for Improved Delivery of Cancer Therapeutics.” Expert Opinion on Therapeutic Targets, vol. 16, May 2012, pp. 635–50. EBSCOhost, https://doi.org/10.1517/14728222.2012.687374.

APA

Jim Klostergaard, Sukhen C. Ghosh, & Sultan Neslihan Alpay. (2012). CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion on Therapeutic Targets, 16, 635–650. https://doi.org/10.1517/14728222.2012.687374

Chicago

Jim Klostergaard, Sukhen C. Ghosh, and Sultan Neslihan Alpay. 2012. “CD44: A Validated Target for Improved Delivery of Cancer Therapeutics.” Expert Opinion on Therapeutic Targets 16 (May): 635–50. doi:10.1517/14728222.2012.687374.